UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                                    FORM 8-K


                             Current Report pursuant
                          to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934


         Date of report (Date of earliest event reported): April 9, 2007


                       METROPOLITAN HEALTH NETWORKS, INC.
             (Exact name of registrant as specified in its charter)


                                     Florida
                 (State or other jurisdiction of incorporation)


                   0-28456                          65-0635748
         (Commission file number)     (I.R.S. Employer Identification No.)

                     250 Australian Avenue South, Suite 400
                            West Palm Beach, FL 33401
          (Address of principal executive offices, including zip code)


                                 (561) 805-8500
              (Registrant's telephone number, including area code)

Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions:

|_|   Written  communications  pursuant to Rule 425 under the Securities Act (17
      CFR 230.425)
|_|   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
      240.14a-12)
|_|   Pre-commencement  communications  pursuant  to  Rule  14d-2(b)  under  the
      Exchange Act (17 CFR 240.14d-2(b))
|_|   Pre-commencement  communications  pursuant  to  Rule  13e-4(c)  under  the
      Exchange Act (17 CFR 240.13e-4(c))



Section 5 - Corporate Governance and Management

Item 5.02.  Departure of Directors or Certain  Officers;  Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

      (b)  On  April  9,  2007  (the  "Separation  Date"),  Metropolitan  Health
Networks,  Inc. (the "Company")  accepted the resignation of Debra A. Finnel for
personal  reasons from her role as President and Chief Operating  Officer of the
Company.  Effective  April 6, 2007,  Ms.  Finnel also resigned from the Board of
Directors of the Company. The termination of these relationships did not involve
any disagreements  between Ms. Finnel and the Company. Ms. Finnel has agreed, to
the extent  reasonably  requested by the Company,  to cooperate with the Company
for ninety days following the Separation  Date in order to generally  assist the
Company with the  transition  to an interim  President of the  Company's  Health
Maintenance Organization (the "HMO").

      The Company has  appointed  an interim  President of the HMO to assist and
lead the HMO for a three month  period  while the Company  conducts a search for
Ms. Finnel's replacement. During the search period, the Company anticipates that
this  interim  President  of the HMO as well as the  Company's  other  executive
officers will assume the duties previously performed by Ms. Finnel.

      (e) In  consideration of Ms. Finnel's long term commitment to the Company,
the  Company  entered  into  a  mutually  agreeable  Separation  Agreement  (the
"Separation  Agreement")  with  Ms.  Finnel  on April 9,  2007.  The  Separation
Agreement  will become  effective  seven days  following the Execution Date (the
"Effective Date") unless revoked by Ms. Finnel prior to the Effective Date.

      The Separation Agreement provides, among other things, that:

      o     Ms. Finnel will receive all base salary,  bonus and unused  vacation
            earned but unpaid through the Separation Date;

      o     Ms.  Finnel  will be  entitled to receive her base salary for twelve
            months following the Separation Date,  payable monthly in accordance
            with the Company's normal payroll practices;

      o     Ms.  Finnel  will be  entitled  to  participate  in  certain  of the
            Company's   benefit   programs  for  twelve  months   following  the
            Separation Date; and

      o     Ms.  Finnel will be entitled to receive an  automobile  allowance of
            $1500 per month and a mobile  telephone  allowance of $250 per month
            for twelve months following the Separation Date.

      All  outstanding  stock options held by Ms. Finnel will remain  subject to
the terms  and  conditions  of the  applicable  Company  stock  option  plan and
agreement evidencing the option.

      Under the  Separation  Agreement,  Ms.  Finnel  has  agreed to be bound by
restrictive covenants regarding,  among others things,  non-competition with the
Company for a one year period, non-solicitation of the Company's employees for a
two-year  period and  confidentiality.  Ms.  Finnel has also  provided a general
release of claims in favor of the Company and related parties.



      The Separation  Agreement  terminates the employment  agreement previously
entered into between the Company and Ms. Finnel.

      The foregoing does not  constitute a complete  summary of the terms of the
Separation  Agreement,  and  reference  is  made  to the  complete  text  of the
Agreement, which is attached hereto as Exhibit 10.1.

Section 9 - Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits

      (d) Exhibits

      10.1 Separation Agreement, dated as of April 9, 2007, by and between Debra
A. Finnel and Metropolitan Health Networks, Inc.

      99.1 Press Release dated April 9, 2007



                                   SIGNATURES

      Pursuant to the  requirements of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

Date:  April 9, 2007


                                   METROPOLITAN HEALTH NETWORKS, INC.



                                   By: /s/ Roberto L. Palenzuela
                                       ----------------------
                                   Roberto L. Palenzuela
                                   Secretary and General Counsel